Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide Effect on HGF in Ischemic Stroke
ChiCTR-OPN-17011341Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical University
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butylphthalide in ischemic stroke and cerebrovascular disease (2 arms), sponsored by The First Affiliated Hospital of Xinxiang Medical University. Primary endpoints: high-sensitivity C-reactive protein, hepatocyte growth factor and 7 more. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic strokecerebrovascular disease
Beyond the preview
Go deeper on ChiCTR-OPN-17011341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17011341.